1. Lipids activate skeletal muscle mitochondrial fission and quality control networks to induce insulin resistance in humans.
- Author
-
Axelrod, Christopher L., Fealy, Ciaran E., Erickson, Melissa L., Davuluri, Gangarao, Fujioka, Hisashi, Dantas, Wagner S., Huang, Emily, Pergola, Kathryn, Mey, Jacob T., King, William T., Mulya, Anny, Hsia, Daniel, Burguera, Bartolome, Tandler, Bernard, Hoppel, Charles L., and Kirwan, John P.
- Subjects
SKELETAL muscle ,INSULIN resistance ,QUALITY control ,INSULIN sensitivity ,TYPE 2 diabetes ,LIPIDS - Abstract
A diminution in skeletal muscle mitochondrial function due to ectopic lipid accumulation and excess nutrient intake is thought to contribute to insulin resistance and the development of type 2 diabetes. However, the functional integrity of mitochondria in insulin-resistant skeletal muscle remains highly controversial. 19 healthy adults (age:28.4 ± 1.7 years; BMI:22.7 ± 0.3 kg/m
2 ) received an overnight intravenous infusion of lipid (20% Intralipid) or saline followed by a hyperinsulinemic-euglycemic clamp to assess insulin sensitivity using a randomized crossover design. Skeletal muscle biopsies were obtained after the overnight lipid infusion to evaluate activation of mitochondrial dynamics proteins, ex-vivo mitochondrial membrane potential, ex-vivo oxidative phosphorylation and electron transfer capacity, and mitochondrial ultrastructure. Overnight lipid infusion increased dynamin related protein 1 (DRP1) phosphorylation at serine 616 and PTEN-induced kinase 1 (PINK1) expression (P = 0.003 and P = 0.008, respectively) in skeletal muscle while reducing mitochondrial membrane potential (P = 0.042). The lipid infusion also increased mitochondrial-associated lipid droplet formation (P = 0.011), the number of dilated cristae, and the presence of autophagic vesicles without altering mitochondrial number or respiratory capacity. Additionally, lipid infusion suppressed peripheral glucose disposal (P = 0.004) and hepatic insulin sensitivity (P = 0.014). These findings indicate that activation of mitochondrial fission and quality control occur early in the onset of insulin resistance in human skeletal muscle. Targeting mitochondrial dynamics and quality control represents a promising new pharmacological approach for treating insulin resistance and type 2 diabetes. NCT02697201 , ClinicalTrials.gov • Insulin resistance is a key pathophysiological mechanism in the development and progression of type 2 diabetes. • Mitochondrial dynamics may mediate the onset of insulin resistance by regulating excess nutrient availability • Intravenous infusion of fatty acids results in lipid accumulation within and surrounding human skeletal muscle mitochondria • Lipid accumulation triggers activation of mitochondrial fission and quality control processes • Mitochondrial respiratory function and ultrastructure remain intact despite the onset of insulin resistance. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF